About Surgalign Holdings, Inc
Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. It offers products for thoracolumbar procedures, including Streamline TL Spinal Fixation system, a system for degenerative and complex spine procedures; and Streamline MIS Spinal Fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical plate system; Fortilink-C IBF system, a cervical interbody fusion device that utilizes TETRAfuse 3D technology; and Streamline OCT system, a range of implants used in the occipito-cervico-thoracic posterior spine. The company also provides motion preservation systems comprising Coflex Interlaminar Stabilization device for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; HPS 2.0 Universal Fixation system, a pedicle screw system used for posterior stabilization of the thoracolumbar spine; SImmetry SI Joint Fusion system, a minimally invasive surgical implant system to decrease opioid use, pain, and disability. In addition, it develops Augmented Reality and Artificial Intelligence digital surgery platform to enable digital spine surgery. The company markets its products through independent spine and biomaterial distributors to hospitals, ambulatory surgery centers, and healthcare providers, as well as through direct sales force. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois. Address: 520 Lake Cook Road, Deerfield, IL, United States, 60015
Surgalign Holdings, Inc News and around…
Latest news about Surgalign Holdings, Inc (SRGA) common stock and company :
Surgalign Holdings Inc (NASDAQ: SRGA) shares are trading lower by 19.73% at $0.15 after the company announced a 1-for-30 reverse stock ...
DEERFIELD, Ill., May 16, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced that at its Annual Meeting of Stockholders (“Annual Meeting”) on May 10, 2022, the Board and stockholders of the Company approved a reverse stock split of the Company’s issued and outstanding shares of its common stock and authorized the Board to select the ratio of the
Gainers Athenex (NASDAQ:ATNX) shares increased by 30.5% to $0.62 during Monday's pre-market session. The market ...
Surgalign Holdings (NASDAQ:SRGA) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need to ...
Gainers Avalon Globocare (NASDAQ:AVCO) stock rose 14.8% to $0.54 during Tuesday's after-market session. The market value of their ...
DEERFIELD, Ill., May 10, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced financial results for its 2022 first quarter ended March 31, 2022. Financial Highlights and Key Events: Received FDA 510(k) clearance for HOLO Portal™ System, the world's first AI-driven AR guidance system for spine surgery;1st Holo Portal™ site up and running;1st succe
The recent price decline of 16% in Surgalign Holdings, Inc.'s ( NASDAQ:SRGA ) stock may have disappointed insiders who...
Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per ...
DEERFIELD, Ill., May 06, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced that it has granted restricted stock unit awards to one (1) employee, who was not an executive officer as an inducement for him to accept employment with Surgalign, and representing the right to receive, in the aggregate, up to 37,500 shares of Surgalign common stock. Th
Indiana Spine Hospital is the first to utilize the HOLO Portal system, the world’s first artificial intelligence (AI) and augmented reality (AR) guidance systemDEERFIELD, Ill., May 05, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced that the Company’s HOLO Portal surgical guidance system has officially entered clinical use. The first procedur
Gainers Sonoma Pharmaceuticals (NASDAQ:SNOA) shares rose 50.7% to $4.01 during Tuesday's pre-market session. The ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips It's time for another dive into the biggest pre-market stock movers for today as we prepare for a busy day of trading on Tuesday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn’t matter if you have $500 in savings or $5 million. Do this now. Get in Now on Tiny $3 ‘Forever Battery’ Stock Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”
Gainers Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) shares rose 38% to $3.69 in pre-market trading. Sonoma Pharmaceuticals and ...
DEERFIELD, Ill., April 26, 2022 (GLOBE NEWSWIRE) -- Surgalign Spine Technologies, (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care through the evolution of digital surgery, today announced it plans to release financial results from the first quarter 2022 after the close of trading on May 10th, 2022. Surgalign will host a conference call and audio webcast at 4:30 p.m. ET the same day. The conference call can be accessed by dialing (866) 604-1616 (U.S.)
Gainers Rockwell Medical (NASDAQ:RMTI) stock rose 9.2% to $0.4 during Monday's after-market session. The company's market cap stands ...
During Friday's morning session, 234 stocks hit new 52-week lows. Interesting Facts About Today's 52-Week ...
Surgalign Holdings Inc(NASDAQ: SRGA) announced thepublication of results from EVoluSIon(EVSI) study of clinical ...
Study published in the IJSS shows Surgalign product to be a reliable solution for SIJ dysfunctionDEERFIELD, Ill., March 24, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced the publication of results from EVoluSIon (EVSI), a large, prospective, multi-center study of clinical outcomes following minimally invasive sacroiliac joint (SIJ) fusion w
Surgalign Holdings (NASDAQ:SRGA) brought in sales totaling $21.83 million during Q4 according to data provided by Benzinga Pro. However, ...
Gainers Sonnet BioTherapeutics (NASDAQ:SONN) stock rose 85.6% to $0.51 during Wednesday's pre-market session. The ...
Gainers Fangdd Network Group Ltd. (NASDAQ: DUO) rose 57.1% to $0.4198 in pre-market trading. KE Holdings Inc. (NYSE: BEKE) ...
Surgalign Holdings (NASDAQ:SRGA) reported its Q4 earnings results on Tuesday, March 15, 2022 at 04:01 PM. Here's what investors ...
DEERFIELD, Ill., March 15, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today reported operating results for the fourth quarter and full year 2021. Recent Highlights: Total global spine revenue of $21.8 million, compared to $26.2 million in the fourth quarter of 2020Net loss from continuing operations of $88.8 million, inclusive of a $72.1 million loss r
Companies Reporting Before The Bell • IDEAYA Biosciences (NASDAQ:IDYA) is likely to report quarterly loss at $0.31 per ...
Surgalign Holdings (NASDAQ:SRGA) is set to give its latest quarterly earnings report on Tuesday, 2022-03-15. Here's what investors need ...
DEERFIELD, Ill., March 08, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced it plans to release financial results from the fourth quarter and full year 2021 after the close of trading on March 15, 2022. Surgalign will host a conference call and audio webcast at 4:30 p.m. ET the same day. The conference call can be accessed by dialing (866) 604
DEERFIELD, Ill., March 07, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (NASDAQ: SRGA) (“Surgalign”), a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced the appointment of David Lyle, as Chief Financial Officer, effective immediately. “David brings a wealth of experience in helping to guide the growth of technologies to Surgalign at an important and exciting inflection point of the company’s evolution,” s
Gainers Surgalign Holdings (NASDAQ:SRGA) shares rose 3.1% to $0.32 during Friday's after-market session. Today's trading volume for ...
Gainers Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) surged 26% to close at $2.24. Y-mAbs reported completion of pre-BLA meeting with ...
US stocks extended losses toward the end of trading session, with the Dow Jones tumbling 450 points on Friday. The Dow traded down ...
Surgalign Holdings, Inc (SRGA) is a NASDAQ Common Stock listed in Common Stock, Healthcare, Medical Devices
